| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/07/2011 | EP2362733A1 Materials and methods to enhance hematopoietic stem cells engraftment procedures |
| 09/07/2011 | EP2362731A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 09/07/2011 | EP2362730A1 Adamantyl benzamide compounds |
| 09/07/2011 | EP2362727A1 Methods for treating resistant diseases using triazole containing macrolides |
| 09/07/2011 | EP2362726A1 Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells |
| 09/07/2011 | EP2362725A1 Antiviral supplement formulations |
| 09/07/2011 | EP2291380B1 Nalmefene prodrugs |
| 09/07/2011 | EP2227476B1 Tricyclic triazolic compounds |
| 09/07/2011 | EP2215085B1 Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
| 09/07/2011 | EP2181104B1 Zearalenone macrolide derivatives and uses of the same |
| 09/07/2011 | EP2152713B1 Pyrazolopyrrolidines as inhibitors of gamma secretase |
| 09/07/2011 | EP2137143B1 Pleuromutilin derivatives for the treatment of diseases mediated by microbes |
| 09/07/2011 | EP2114933B1 Piperidine gpcr agonists |
| 09/07/2011 | EP2101790B1 Combination comprising sapacitibine (2'-cyano-2'-deoxy-n4-palmitoyl-1-beta-d-arabinofuranosyl-cytosine) and a cytotoxic agent |
| 09/07/2011 | EP2100605B1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer |
| 09/07/2011 | EP2097388B1 Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
| 09/07/2011 | EP2070926B1 13,13a-dihydroberberine derivatives, their pharmaceutical composition and use |
| 09/07/2011 | EP2069315B1 Quinazolinone and isoquinolinone acetamide derivatives |
| 09/07/2011 | EP2069301B1 Process for the preparation of pleuromutilins |
| 09/07/2011 | EP2066640B1 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives |
| 09/07/2011 | EP2065388B1 Pyrazolopyrimidine derivative |
| 09/07/2011 | EP2049500B1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors |
| 09/07/2011 | EP2046737B1 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 09/07/2011 | EP2029591B1 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof |
| 09/07/2011 | EP1963288B1 Substituted oxazole derivatives with an analgesic action |
| 09/07/2011 | EP1924252B1 Method for improving cell permeability to foreign particles |
| 09/07/2011 | EP1910299B1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 09/07/2011 | EP1904442B1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 09/07/2011 | EP1879854B1 Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid |
| 09/07/2011 | EP1877383B1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity |
| 09/07/2011 | EP1863475B1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 09/07/2011 | EP1853583B1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 09/07/2011 | EP1853568B1 Hiv inhibiting 2-(4-cyanophenylamino)pyrimidine derivatives |
| 09/07/2011 | EP1850851B1 Pyrrolo[2,3-d]pyrimidines for treating cancer by inhibiting mitosis |
| 09/07/2011 | EP1845095B1 1-thio-d-glucitol derivatives |
| 09/07/2011 | EP1812007B1 Pyridazine compounds and methods |
| 09/07/2011 | EP1809280B1 Mitotic kinesin inhibitors and methods of use thereof |
| 09/07/2011 | EP1807107B1 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 09/07/2011 | EP1805164B9 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/07/2011 | EP1761490B1 3'-alkoxy spirocyclic tetramic and tetronic acids |
| 09/07/2011 | EP1239862B3 Pharmaceutical preparation containing cytostatic agents and electron acceptors for treating tumor diseases |
| 09/07/2011 | CN201959275U 用于治疗结核病的片剂胶囊 Tablets for the treatment of tuberculosis capsule |
| 09/07/2011 | CN201959274U 同时装有利福平片、异烟肼片、盐酸乙胺丁醇片的胶囊 Meanwhile equipped with rifampicin tablets, isoniazid tablets, capsules ethambutol hydrochloride tablets |
| 09/07/2011 | CN1990475B Substituted benzisoselenazolone compounds and use thereof |
| 09/07/2011 | CN1981744B Production of injection slow-releasing micropills of lycopodine and its derivative |
| 09/07/2011 | CN1933833B Aqueous composition comprising thiazole derivative |
| 09/07/2011 | CN1914182B Quinazoline derivatives |
| 09/07/2011 | CN1817882B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/07/2011 | CN1787817B 免疫抑制剂化合物及组合物 Immunosuppressive compounds and compositions |
| 09/07/2011 | CN1660428B New application of synthase inhibitor of nitric in use for treating hemorrhoid |
| 09/07/2011 | CN1582150B Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 09/07/2011 | CN102177180A Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
| 09/07/2011 | CN102177172A Compounds and pharmaceutical compositions for the treatment of viral infections |
| 09/07/2011 | CN102177162A NFAT signal inhibitor and hair-growing agent |
| 09/07/2011 | CN102177161A Pyrimidinyl pyridone inhibitors of JNK |
| 09/07/2011 | CN102177160A 18F-labelled folates as PET radiotracers |
| 09/07/2011 | CN102177159A Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/07/2011 | CN102177158A A crystalline form of 4- (5-{ (iR) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } - 4 -methyl- 4H- 1, 2,4- triazol-3-yl) pyridine |
| 09/07/2011 | CN102177157A Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators |
| 09/07/2011 | CN102177154A Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
| 09/07/2011 | CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases |
| 09/07/2011 | CN102177152A Halofuginone analogs for inhibition of tRNA synthetases and uses thereof |
| 09/07/2011 | CN102177151A Modulators for amyloid beta |
| 09/07/2011 | CN102177150A Dithiolane compounds, composition including compounds and uses in protection of skin |
| 09/07/2011 | CN102177147A Processes for the preparation of SGLT2 inhibitors |
| 09/07/2011 | CN102177144A Crystalline forms of (R) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [Z] ylidene] -2- ( [Z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
| 09/07/2011 | CN102177141A Bi-1H-benzimidazoles as hepatitis C virus inhibitors |
| 09/07/2011 | CN102177137A 1-phenylpyrrole compounds |
| 09/07/2011 | CN102177136A Pyrrolidine N-benzyl derivatives |
| 09/07/2011 | CN102177133A Tetrahydronaphthalene compounds |
| 09/07/2011 | CN102176920A Curcuminoids and its metabolites for the application in ocular diseases |
| 09/07/2011 | CN102176918A Treating or preventing gout |
| 09/07/2011 | CN102176916A Acne treatment compositions comprising nanosilver and uses |
| 09/07/2011 | CN102176915A Pharmaceutical composition with glycosaminoglycans and use thereof in the treatment of chronic ulcers |
| 09/07/2011 | CN102176914A VHZ for diagnosis and treatment of cancers |
| 09/07/2011 | CN102176913A Tacrolimus preparation for external applications |
| 09/07/2011 | CN102176912A 5,6-dihydro-1H-pyridin-2-one compounds |
| 09/07/2011 | CN102176911A Novel adenine derivatives |
| 09/07/2011 | CN102176910A A new crystalline form of 4- (5- { (IR) -1- [5- (3- chlorophenyl) isoxazol-3-yl] ethoxy } -4-methyl-4H-l, 2, 4- triazol-3-yl) pyridine |
| 09/07/2011 | CN102176909A 2-hydroxy-ethanesulfonate salt |
| 09/07/2011 | CN102176908A Combination therapy comprising angiotensin receptor blockers and vasopressin receptor antagonists |
| 09/07/2011 | CN102176907A Oral vaccines for producing mucosal immunity |
| 09/07/2011 | CN102176906A Novel use of panduratin derivative or boesenbergia pandurata extract |
| 09/07/2011 | CN102176902A Using of organic solvents in wet granulation of moxifloxacin |
| 09/07/2011 | CN102176900A Pharmaceutical compositions and related methods of delivery |
| 09/07/2011 | CN102176899A Benzimidazole anthelmintic compositions |
| 09/07/2011 | CN102176828A Antifungal agents |
| 09/07/2011 | CN102176827A Antifungal agents |
| 09/07/2011 | CN102176826A Substituted triazolo-pyridazine derivatives |
| 09/07/2011 | CN102176825A Flavin derivatives |
| 09/07/2011 | CN102174614A Antarctic cold-adapted microbial extracellular polysaccharide capable of improving body immunity |
| 09/07/2011 | CN102174438A Deminamicin and preparation method and application thereof |
| 09/07/2011 | CN102174123A Production method of water soluble flavone-chitosan derivative |
| 09/07/2011 | CN102174117A Method for preparing Stachys floridana schuttl.Exbent. polysaccharide with antitumor activity |
| 09/07/2011 | CN102174106A Anti-Met humanized Fab, anti-Met humanized Fab and doxorubicin conjugate and preparation method and application of anti-Met humanized Fab and doxorubicin conjugate |
| 09/07/2011 | CN102174065A Triazolyl containing pentacyclic triterpenoid derivatives and preparation method and medicinal application thereof |
| 09/07/2011 | CN102174058A Antitumoral compounds |
| 09/07/2011 | CN102174054A 5-aryl-3-(2-pyridyl)-4,5-dihydro-pyrazole-1-thioamide Au (III) complex with anti-tumor activity |
| 09/07/2011 | CN102174048A Novel polymorphic form beta of soporifics |
| 09/07/2011 | CN102174046A Tetomilast polymorphs |